Elevation of tumor necrosis factor-α and increased risk of recurrent coronary events after myocardial infarction

Circulation

Volumn 101, Issue 18, 2000, Pages 2149-2153

  Ridker, Paul M ^a   Rifai, Nader ^b   Pfeffer, Marc ^a   Sacks, Frank ^a   Lepage, Serge ^c   Braunwald, Eugene ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

Atherosclerosis; Inflammation; Myocardial infarction; Tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY RISK; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; FEMALE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; RISK ASSESSMENT;

EID: 0034625079     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.18.2149     Document Type: Article

References (31)

1. Warner SJC, Libby P. Human vascular smooth muscles: target for and source of tumor necrosis factor. J Immunol. 1989;142:100-109.
2. Tipping PG, Hancock WW. Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques. Am J Pathol. 1994;142:1721-1782.
3. Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS. Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol. 1990;65:297-302.
4. Old LJ. Tumor necrosis factor (TNF). Science. 1985;230:630-632.
5. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236-241.
6. McMurray J, Abdullah I, Dargie H, Shapiro D. Increased concentrations of tumour necrosis factor in "cachectic" patients with severe heart failure. Br Heart J. 1991;66:356-358.
7. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest. 1993;92: 2303-2312.
8. Lo SK, Everitt J, Gu J, Malik AB. Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanisms. J Clin Invest. 1992;89:981-988.
9. Horgan MJ, Palace GP, Everitt JE, Malik AB. TNF-α release in endotoxemia contributes to neutrophil-dependent pulmonary edema. Am J Physiol. 1993;264:H1161-H1165.
10. Hegewisch S, Weh HJ, Hossfeld DK. TNF-induced cardiomyopathy. Lancet. 1990;2:294-295.
11. Vaddi K, Nicolini FA, Mehta P, Mehta JL. Increased secretion of tumour necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease: relevance in superoxide anion generation. Circulation. 1994;90:694-699.
12. Kulkeilka GL, Smith CW, Maning AM, Yonker KA, Micheal KH, Entman ML. Induction of interleukin synthesis in the myocardium. Circulation. 1995;92:1866-1875.
13. Herskowitz A, Choi S, Ansari AA, Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol. 1995; 146:419-428.
14. Chandrasekar B, Freeman GL. Induction of nuclear factor κB and activation of protein 1 in postischemic myocardium. FEBS Lett. 1997;401: 30-34.
15. Irwin MW, Mak S, Mann DL, Qu R, Penninger JM, Van A, Dawood F, Wen W-H, Shou Z, Liu P. Tissue expression and immunolocalization of tumor necrosis factor-α in postinfarction dysfunctional myocardium. Circulation. 1999;99:1492-1498.
16. Maury CPJ, Teppo AM. Circulating tumor necrosis factor-α (cachectin) in myocardial infarction. J Intern Med. 1989;225:333-336.
17. Basaran Y, Basaran MM, Babacan KF, Ener B, Okay T, Gok H, Ozdemir M. Serum tumor necrosis factor levels in acute myocardial infarction and unstable angina pectoris. Angiology. 1993;44:332-337.
18. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JMO, Wun C, Davis BR, Braunwald E, for the Cholesterol And Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335:1001-1009.
19. Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Moye LA, Goldman S, Flaker GC, Braunwald E, for the Cholesterol And Recurrent Events (CARE) Investigators. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation. 1998;98:839-844.
20. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448-454.
21. Marx N, Neumann F-J, Ott I, Gawaz M, Koch W, Pinkau T, Schomig A. Induction of cytokine expression in leukocytes in acute myocardial infarction. J Am Coll Cardiol. 1997;30:165-170.
22. Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A, Summaria F, Ginnetti F, Fadda G, Maseri A. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation. 1999;99:855-860.
23. Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB, for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 1997;349:462-466.
24. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 1994;331: 417-424.
25. Morrow DA, Rifai N, Amman EM, Weiner DL, McCabe C, Cannon CP, Braunwald E. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. J Am Coll Cardiol. 1998;31: 1460-1465.
26. Biasucci LM, Bitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rebuzzi AG, Ciliberto G, Maseri A. Elevated levels of interleukin-6 in unstable angina. Circulation. 1996;94:874-877.
27. Biasucci LM, Liuzzo G, Fantuzzi G, Caligiuri G, Rebuzzi AG, Ginnetti F, Dinarello CA, Maseri A. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation. 1999;99:2079-2084.
28. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 1995;91:2844-2850.
29. Ross R. Mechanisms of disease: atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
30. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.
31. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 1998;97:2007-2011.